Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -516,755 | -703,488 | -594,244 | -336,506 | -105,025 |
| Depreciation Amortization | 2,654 | 31,213 | 26,793 | 19,149 | 10,669 |
| Accounts receivable | -9,208 | -61,638 | -48,519 | -50,864 | -25,204 |
| Other Working Capital | -121,577 | -39,470 | 11,923 | 1,937 | -43,517 |
| Other Operating Activity | 435,490 | 448,037 | 371,093 | 198,294 | 61,902 |
| Operating Cash Flow | $-209,396 | $-325,346 | $-232,954 | $-167,990 | $-101,175 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,071 | N/A | -1,032,594 | -1,060,451 | -779,770 |
| PPE Investments | -9,485 | -30,824 | -22,860 | -14,629 | -5,551 |
| Purchase Of Investment | N/A | -1,937,856 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 923,224 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -94 | -1,427 | -1,225 | 0 | N/A |
| Other Investing Activity | -94 | -1,427 | -1,225 | -718 | -486 |
| Investing Cash Flow | $12,492 | $-1,046,883 | $-1,056,679 | $-1,075,798 | $-785,807 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,127,400 | 1,127,400 | N/A | N/A |
| Debt Repayment | N/A | -823,232 | -823,232 | N/A | N/A |
| Common Stock Issued | 28,037 | 30,043 | 18,740 | 5,329 | 4,990 |
| Other Financing Activity | 73,758 | -101,704 | -101,150 | 0 | 0 |
| Financing Cash Flow | $101,795 | $232,507 | $221,758 | $5,329 | $4,990 |
| Beginning Cash Position | 985,801 | 2,125,523 | 2,125,523 | 2,125,523 | 2,125,523 |
| End Cash Position | 890,692 | 985,801 | 1,057,648 | 887,064 | 1,243,531 |
| Net Cash Flow | $-95,109 | $-1,139,722 | $-1,067,875 | $-1,238,459 | $-881,992 |
| Free Cash Flow | |||||
| Operating Cash Flow | -209,396 | -325,346 | -232,954 | -167,990 | -101,175 |
| Capital Expenditure | -9,485 | -30,824 | -22,860 | -14,629 | -5,551 |
| Free Cash Flow | -218,881 | -356,170 | -255,814 | -182,619 | -106,726 |